ZGGS-18

N/A

Report date: 2024/08/21 16:31:37

Base Information

Drug NameZGGS-18

Drug Alias NameZGGS18ZGGS-18GS18

ClassificationBiologics > Protein drugs > Recombinant protein > Fusion proteinBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Multispecific monoclonal antibody > Bispecific monoclonal antibody

Mechanisms of ActionAnti-Vascular endothelial growth factorAnti-TGF-β

TargetsVascular endothelial growth factorTransforming growth factor beta

Therapy Area/IndicationsSolid tumours

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited StatesMainland China

CombinationsNo

Global Highest StatusPhase 2 Clinical

Highest Status in ChinaPhase 2 Clinical

Originator CompaniesSuzhou Zelgen Biopharmaceuticals Co Ltd

China Registration ClassClass 1 therapeutic biologic in China

Develop Information

Active CompaniesSuzhou Zelgen Biopharmaceuticals Co Ltd

Inactive CompaniesN/A

Active IndicationsSolid tumours

Inactive IndicationsN/A

Other Information

ATC CodeN/A